Clinical TrialsSearch results
Number of results: 314
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase II/III study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-03-16
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Other
- Effects of a traditional Japanse herbal medicine yokukansan (YKS) for BPSD in DLB
- Dementia with Lewy bodies (DLB), Parkinson disease with dementia (PDD)
- yokukansan-DLB research group
- 2008-11-20
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01
Other
- Multicenter phase II study of modified FOLFOX6 and bevacizumab in chemonaive advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2008-11-10
Other
- A genotype directed dose-finding study of Irinotecan (CPT-11) by groups of Uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphisms in patients with advanced metastatic colorectal cancer and gastric cancer.
- colorectal cancer/ gastric cancer
- Yakult Honsha Co.,Ltd
- 2006-11-01
Other
- Randomized controlled trial of mizoribine for progressive IgA nephropathy
- IgA nephropathy with moderate to severe histological alterations
- West Japan Study Group for Therapy of IgA Nephropathy
- 2007-02-05
Other
- A phase III trial comparing preoperative chemotherapy to chemoradiotherapy before surgery in patients with pathologically-confirmed stage IIIA-N2 non-small cell lung cancer.
- Pathologically confirmed stage IIIA-N2 non-small cell lung cancer
- West Japan Oncology Group
- 2005-09-14